C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/10 (2006.01) A61K 31/438 (2006.01) A61P 3/04 (2006.01) A61P 3/08 (2006.01) A61P 15/00 (2006.01) C07D 221/20 (2006.01) C07D 401/06 (2006.01) C07D 491/10 (2006.01)
Patent
CA 2520114
Certain novel N-acylated spiropiperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
L'invention concerne des dérivés de spiropipéridine N-acylés utilisés comme agonistes vis-à-vis du ou des récepteurs de mélanocortine de type humain, et en particulier comme agonistes sélectifs vis-à-vis du récepteur de mélanocortine-4 (MC-4R). Ces dérivés sont donc utiles pour le traitement, le contrôle ou la prévention des maladies répondant à l'activation du MC-4R, à savoir par exemple : obésité, diabète, dysfonctionnement sexuel, y compris le dysfonctionnement de l'érection et le dysfonctionnement sexuel chez la femme
Guo Liangqin
He Shuwen
Jian Tianying
Lai Yingjie
Liu Jian
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Acylated spiropiperidine derivatives as melanocortin-4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated spiropiperidine derivatives as melanocortin-4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated spiropiperidine derivatives as melanocortin-4... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1793270